Coronary artery bypass grafting remains the preferred revascularization strategy over percutaneous coronary intervention for patients with heavy atherosclerotic burden, multivessel disease, and diabetes.
Coronary revascularization has matured as a field since coronary artery bypass grafting (CABG) was first developed over 50 years ago, with diagnostic and treatment methods having advanced dramatically. CABG remains the standard of care for obstructive coronary artery disease, particularly for patients with multivessel disease or diabetes. It is now recognized that not all CABG is created equal—operative strategy, including conduit choice for bypass grafts and target coronary selection, affects survival. A multidisciplinary approach including surgeons with a special interest in CABG is recommended to optimize treatment selection and outcomes.
Dimeling et al. (Sat,) conducted a review in Coronary artery disease. Coronary artery bypass grafting (CABG) vs. Percutaneous coronary intervention (PCI) was evaluated. Coronary artery bypass grafting remains the preferred revascularization strategy over percutaneous coronary intervention for patients with heavy atherosclerotic burden, multivessel disease, and diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: